ReviewCurrent drug research reviews2026
Navigating Global Cosmetics Compliance: A Comparative Analysis of India's Cosmetics Rules 2020 with International Standards.
Review in Current drug research reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Indian cosmetics industry has undergone a significant transformation with the implementation of the Cosmetics Rules 2020, which seek to align the country's regulatory framework with international standards, address local challenges, and ensure consumer safety. These rules cover registration and licensing, labeling and packaging, and stringent safety standards, ensuring the production of high-quality, safe products. This review provides a detailed comparative analysis of India's new regulations with those in major markets, including the European Union (EU), the United States (US), and Japan, as well as emerging markets such as China, Brazil, and Southeast Asia. The analysis highlights key similarities and differences, identifies areas for further reform, and offers insights into global regulatory dynamics. The review examines critical aspects such as registration and licensing requirements, which are essential for market entry. It also scrutinizes labeling and packaging regulations, which promote consumer transparency. Safety standards are a focal point, given their importance in protecting consumers. The impact of these regulations on India's cosmetics industry is explored, emphasizing the growing importance of sustainable practices, digital labeling, and traceability systems. These technologies enhance consumer access to product information and ensure product authenticity and safety throughout the supply chain. Furthermore, this review provides a future outlook, suggesting areas for regulatory improvement to support continued industry growth and consumer protection by examining current regulations and emerging trends.
Indexed as
Identifiers
42734234What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.